AUPH Insider Trading Activity and SEC Form 4 Filings
AUPH insider trading summary
Over the past 12 months, insiders at Aurinia Pharmaceuticals Inc. (AUPH) reported 16 open-market purchases worth $37.6M by 2 insiders and 2 sales worth $546K by 1 insider on SEC Form 4. Net insider buying was $37.1M.
Latest AUPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Stephen P. Robertson | Chief Legal Officer | Sell | $190K (11,939 @ $15.95) |
| Aug 21, 2026 | Stephen P. Robertson | Chief Legal Officer | Sell | $356K (20,975 @ $16.97) |
| Jun 2, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $3.1M (206,005 @ $15.28) |
| Jun 2, 2026 | Kevin Tang | Chief Executive Officer | Buy | $3.1M (206,005 @ $15.28) |
| Jun 1, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $5.2M (343,521 @ $15.28) |
| Jun 1, 2026 | Kevin Tang | Chief Executive Officer | Buy | $5.2M (343,521 @ $15.28) |
| Jun 1, 2026 | Kevin Tang | Chief Executive Officer | Buy | $2K (99 @ $15.34) |
| Jun 1, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $2K (99 @ $15.34) |
| May 29, 2026 | Kevin Tang | Chief Executive Officer | Buy | $35K (2,299 @ $15.35) |
| May 29, 2026 | Tang Capital Management LLC | 10% Owner | Buy | $35K (2,299 @ $15.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.